151 related articles for article (PubMed ID: 9669469)
1. Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study.
Lindberg C; Andersen O; Lefvert AK
Acta Neurol Scand; 1998 Jun; 97(6):370-3. PubMed ID: 9669469
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis.
Ozawa Y; Uzawa A; Kanai T; Oda F; Yasuda M; Kawaguchi N; Himuro K; Kuwabara S
J Neurol Sci; 2019 Jul; 402():12-15. PubMed ID: 31100651
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R;
Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163
[TBL] [Abstract][Full Text] [Related]
4. Initial deterioration and intravenous methylprednisolone therapy in patients with myasthenia gravis.
Sugimoto T; Ochi K; Ishikawa R; Tazuma T; Hayashi M; Mine N; Naito H; Nomura E; Kohriyama T; Yamawaki T
J Neurol Sci; 2020 May; 412():116740. PubMed ID: 32145521
[TBL] [Abstract][Full Text] [Related]
5. Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis.
Komiyama A; Arai H; Kijima M; Hirayama K
J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):214-7. PubMed ID: 10644791
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study.
Zhang KY; Duan WW; Luo YB; Li Y; Hu J; Yang H
Orphanet J Rare Dis; 2024 Jan; 19(1):19. PubMed ID: 38243274
[TBL] [Abstract][Full Text] [Related]
7. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
8. Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis.
Uzawa A; Suzuki S; Kuwabara S; Akamine H; Onishi Y; Yasuda M; Ozawa Y; Kawaguchi N; Kubota T; Takahashi MP; Suzuki Y; Watanabe G; Kimura T; Sugimoto T; Samukawa M; Minami N; Masuda M; Konno S; Nagane Y; Utsugisawa K
Neurotherapeutics; 2023 Mar; 20(2):518-523. PubMed ID: 36607596
[TBL] [Abstract][Full Text] [Related]
9. Pulse Dose Methylprednisolone Therapy for Adult Idiopathic Inflammatory Myopathy.
Raghu P; Manadan AM; Schmukler J; Mathur T; Block JA
Am J Ther; 2015; 22(4):244-7. PubMed ID: 25490616
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
Visser LH; Beekman R; Tijssen CC; Uitdehaag BM; Lee ML; Movig KL; Lenderink AW
Mult Scler; 2004 Feb; 10(1):89-91. PubMed ID: 14760960
[TBL] [Abstract][Full Text] [Related]
11. Treatment of severe idiopathic orbital inflammation with intravenous methylprednisolone.
Bijlsma WR; Paridaens D; Kalmann R
Br J Ophthalmol; 2011 Aug; 95(8):1068-71. PubMed ID: 21349945
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and prognosis of myasthenia gravis in older people.
Evoli A; Batocchi AP; Minisci C; Di Schino C; Tonali P
J Am Geriatr Soc; 2000 Nov; 48(11):1442-8. PubMed ID: 11083321
[TBL] [Abstract][Full Text] [Related]
13. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.
Zivadinov R; Rudick RA; De Masi R; Nasuelli D; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
Neurology; 2001 Oct; 57(7):1239-47. PubMed ID: 11591843
[TBL] [Abstract][Full Text] [Related]
14. Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis.
Yoshikawa H; Kiuchi T; Saida T; Takamori M
J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):970-7. PubMed ID: 21784757
[TBL] [Abstract][Full Text] [Related]
15. A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus.
Mackworth-Young CG; David J; Morgan SH; Hughes GR
Ann Rheum Dis; 1988 Jun; 47(6):496-502. PubMed ID: 3289511
[TBL] [Abstract][Full Text] [Related]
16. Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Guillain-Barré Syndrome Steroid Trial Group.
Lancet; 1993 Mar; 341(8845):586-90. PubMed ID: 8094828
[TBL] [Abstract][Full Text] [Related]
17. [Integrated traditional Chinese and Western medicine in treating 31 cases of myasthenia gravis].
Chen SL; Liu XY; Zhang WX
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):964-7. PubMed ID: 18782544
[No Abstract] [Full Text] [Related]
18. Efficacy of low-dose FK506 in the treatment of Myasthenia gravis--a randomized pilot study.
Nagane Y; Utsugisawa K; Obara D; Kondoh R; Terayama Y
Eur Neurol; 2005; 53(3):146-50. PubMed ID: 15900097
[TBL] [Abstract][Full Text] [Related]
19. A Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia Gravis.
Sanders DB; Rosenfeld J; Dimachkie MM; Meng L; Malik FI;
Neurotherapeutics; 2015 Apr; 12(2):455-60. PubMed ID: 25742919
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]